Skip to content

Author

Núria Aeschlimann

We have 1 of 2 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Jul 2026

KRAS-mutated Non-Small Cell Lung Cancer: Drugging the Undruggable.

New direct inhibitor classes have emerged recently, including tri-complex ON-state inhibitors and dual-state ON/OFF inhibitors capable of targeting not only KRASG12C but also other KRAS mutations, as well as panKRAS and panRAS strategies.

Tämer El Saadany, Núria Aeschlimann, A. Sacher · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.